Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)
The Pharmacogenomics Journal2014Vol. 14(4), pp. 336–342
Citations Over TimeTop 12% of 2014 papers
Aparna Chhibber, Joel Mefford, Eli A. Stahl, Sarah A. Pendergrass, R. Michael Baldwin, Kouros Owzar, M. Li, Eric P. Winer, Clifford A. Hudis, Hitoshi Zembutsu, M. Kubo, Yusuke Nakamura, Howard L. McLeod, Mark J. Ratain, Lawrence N. Shulman, Marylyn D. Ritchie, Robert M. Plenge, John S. Witte, Deanna L. Kroetz
Related Papers
- → Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis(2019)38 cited
- → Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity(2016)18 cited
- → Comparison of Efficacy and Peripheral Neuropathy of Solvent-based Paclitaxel with Paclitaxel Poliglumex and NK105: A Systematic Review and Metaanalysis(2020)8 cited
- [Chemotherapy-induced peripheral neuropathy; impact on quality of life].(2014)
- The relationship of insulin-Like growth factor-1 to diabetic peripheral neuropathy(2001)